Cartesian Therapeutics Inc. (RNAC)

Cartesian Therapeutics Inc. (RNAC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $202M; returns 1 day -3.6%, 1 week -1.4%, 1 year -31.3%.

Cartesian Therapeutics (formerly Selecta Biosciences) is a clinical-stage biotechnology company that transitioned its focus toward RNA-engineered cell therapies following its 2023 merger with Cartesian.

Groups RNAC belongs to

• Clinical Stage Biotech
• Biotechnology
• Autoimmune Diseases
• Healthcare
• Life Sciences
• Immunotherapy
• Autologous Cell Therapy

RNAC financial model: income statement, cash flow and balance sheet